Retour à l'accueil - Logo CERMN

EA 4258 | Centre d'études et de recherche sur le médicament de Normandie

Accueil > Production scientifique > Publications


Publications

Publications 2020


(193)     Dubost, E.; McErlain, H.; Babin, V.; Sutherland, A.; Cailly, T. Recent Advances in Synthetic Methods for Radioiodination. J. Org. Chem. 2020, 85 (13), 8300–8310.
https://doi.org/10.1021/acs.joc.0c00644

(192)     Benabderrahmane, M.; Bureau, R.; Voisin-Chiret, A. S.; Sopkova-de Oliveira Santos, J. Insights into Mcl-1 Conformational States and Allosteric Inhibition Mechanism from Molecular Dynamics Simulations, Enhanced Sampling, and Pocket Crosstalk Analysis. J. Chem. Inf. Model. 2020, 60 (6), 3172–3187.
https://doi.org/10.1021/acs.jcim.0c00315

(191)    Hédou, D.; Voisin-Chiret, A. S. Br vs. TsO Chemoselective Suzuki-Miyaura Cross-Coupling Reaction on Nicotinaldehyde Moiety for the Preparation of 2,3,5-Trisubstituted Pyridines. European J. Org. Chem. 2020, 2020 (24), 3640–3649.
https://doi.org/10.1002/ejoc.202000417

(190)     Valle-Casuso, J.-C.; Gaudaire, D.; Martin-Faivre, L.; Madeline, A.; Dallemagne, P.; Pronost, S.; Munier-Lehmann, H.; Zientara, S.; Vidalain, P.-O.; Hans, A. Replication of Equine Arteritis Virus Is Efficiently Suppressed by Purine and Pyrimidine Biosynthesis Inhibitors. Sci. Rep. 2020, 10 (1), 10100.
https://doi.org/10.1038/s41598-020-66944-4

(189)     Percelay, S.; Since, M.; Lagadu, S.; Freret, T.; Bouet, V.; Boulouard, M. Antipsychotic Lurasidone: Behavioural and Pharmacokinetic Data in C57BL/6 Mice. Pharmacol. Biochem. Behav. 2020, 194 (May), 172933.
https://doi.org/10.1016/j.pbb.2020.172933

(188)    Rochais, C.; Lecoutey, C.; Hamidouche, K.; Giannoni, P.; Gaven, F.; Cem, E.; Mignani, S.; Baranger, K.; Freret, T.; Bockaert, J.; Rivera, S.; Boulouard, M.; Dallemagne, P.; Claeysen, S. Donecopride, a Swiss Army Knife with Potential against Alzheimer’s Disease. Br. J. Pharmacol. 2020, 177 (9), 1988–2005.
https://doi.org/10.1111/bph.14964.

(187)     Garrido, A.; Lepailleur, A.; Mignani, S. M.; Dallemagne, P.; Rochais, C. HERG Toxicity Assessment: Useful Guidelines for Drug Design. Eur. J. Med. Chem. 2020, 195, 112290.
https://doi.org/10.1016/j.ejmech.2020.112290.

(186)     Pedron, J.; Boudot, C.; Brossas, J.-Y.; Pinault, E.; Bourgeade-Delmas, S.; Sournia-Saquet, A.; Boutet-Robinet, E.; Destere, A.; Tronnet, A.; Bergé, J.; Bonduelle, C.; Deraeve, C.; Pratviel, G.; Stigliani, J.-L.; Paris, L.; Mazier, D.; Corvaisier, S.; Since, M.; Malzert-Fréon, A.; Wyllie, S.; Milne, R.; Fairlamb, A. H.; Valentin, A.; Courtioux, B.; Verhaeghe, P. New 8-Nitroquinolinone Derivative Displaying Submicromolar in Vitro Activities against Both Trypanosoma Brucei and Cruzi. ACS Med. Chem. Lett. 2020, 11 (4), 464–472.
https://doi.org/10.1021/acsmedchemlett.9b00566.

(185)     Adnet, T.; Groo, A.; Picard, C.; Davis, A.; Corvaisier, S.; Since, M.; Bounoure, F.; Rochais, C.; Pluart, L. Le; Dallemagne, P.; Malzert-Fréon, A. Pharmacotechnical Development of a Nasal Drug Delivery Composite Nanosystem Intended for Alzheimer’s Disease Treatment. Pharmaceutics 2020, 12 (3), 251.
https://doi.org/10.3390/pharmaceutics12030251.

(184)     Lalut, J.; Payan, H.; Davis, A.; Lecoutey, C.; Legay, R.; Sopkova-de Oliveira Santos, J.; Claeysen, S.; Dallemagne, P.; Rochais, C. Rational Design of Novel Benzisoxazole Derivatives with Acetylcholinesterase Inhibitory and Serotoninergic 5-HT4 Receptors Activities for the Treatment of Alzheimer’s Disease. Sci. Rep. 2020, 10 (1), 3014.
https://doi.org/10.1038/s41598-020-59805-7.

(183)     Denis, C.; Sopková-de Oliveira Santos, J.; Bureau, R.; Voisin-Chiret, A. S. Hot-Spots of Mcl-1 Protein. J. Med. Chem. 2020, 63 (3), 928–943.
https://doi.org/10.1021/acs.jmedchem.9b00983.

(182)     Dallemagne, P.; Rochais, C. Facing the Complexity of Alzheimer’s Disease. Future Med. Chem. 2020, 12 (3), 175–177.
https://doi.org/10.4155/fmc-2019-0310.

(181)     Babin, V.; Tournier, B. B.; Davis, A.; Dubost, E.; Pigrée, G.; Lohier, J.; Reboul, V.; Cailly, T.; Bouillon, J.; Millet, P.; Fabis, F. Design of Iodinated Radioligands for SPECT Imaging of Central Human 5-HT4R Using a Ligand Lipophilicity Efficiency Approach. Bioorg. Chem. 2020, 96, 103582.
https://doi.org/10.1016/j.bioorg.2020.103582.

(180)     De Pascale, M.; Iacopetta, D.; Since, M.; Corvaisier, S.; Vie, V.; Paboeuf, G.; Hennequin, D.; Perato, S.; De Giorgi, M.; Sinicropi, M. S.; Sopkova-De Oliveira Santos, J.; Voisin-Chiret, A.S.; Malzert-Freon, A. Synthesis of Pyridoclax Analogues: Insight into Their Druggability by Investigating Their Physicochemical Properties and Interactions with Membranes. ChemMedChem 2020, 15 (1), 136–154.
https://doi.org/10.1002/cmdc.201900542.

(179)     Gozzi, G. J.; Gonzalez, D.; Boudesco, C.; Dias, A. M. M.; Gotthard, G.; Uyanik, B.; Dondaine, L.; Marcion, G.; Hermetet, F.; Denis, C.; Hardy, L.; Suzanne, P.; Douhard, R.; Jego, G.; Dubrez, L.; Demidov, O.N.; Neiers, F.; Briand, L.; Sopková-de Oliveira Santos, J.; Voisin-Chiret, A.S.; Garrido, C. Selecting the First Chemical Molecule Inhibitor of HSP110 for Colorectal Cancer Therapy. Cell Death Differ. 2020, 27 (1), 117–129.
https://doi.org/10.1038/s41418-019-0343-4.





Télécharger la page

Dernière modification : 2 juillet 2020



Université de Caen Normandie
CERMN Centre détudes et de recherche sur le médicament de Normandie
Boulevard Becquerel | 14032 Caen Cedex | France